Biostatistics, Multiple Testing, Biomarker Development, Normalization and Signal Processing in Omics data, Pathway Analysis and Genetic Mediation Models, Microbiome based biomarker discovery, Marker development for prognosis and diagnosis in concussion and mild traumatic brain injury.
As a Professor of Biostatistics in the Department of Biostatistics at the State University of New York at Buffalo (SUNYAB), Jeffrey Miecznikowski's research broadly consists of two components. The first component is the development and extension of statistical theory and methods. The second component is a substantial biostatistical interdisciplinary element focused largely but not limited to the health sciences.
Biological Networks: High-dimensional omics data can be analyzed to understand the effects of variables on a response. For understanding the underlying biological mechanism affecting the target, it is important to discover the complete set of relevant variables. Thus, in this context, variable selection is the primary goal. Of special interest are functional modules, i.e., cooperating sets of variables affecting the target which can be characterized by a graph. Our contributions in this area propose new methods to determine the functional modules or sets of variables. We have extended this research to use statistical methods to identify mediating processes or pathways that are important for understanding the causation of an outcome of interest such as disease. An example is genome-wide association studies (GWAS) where considering gene expression as an intermediate step to disease may explain the association of disease with a host’s genotype.
Error Control: The problem of assessing the significance of a single test in light of performing many tests has long been a challenge for statisticians. With the advent of modern ‘omics platforms, there are thousands (or millions) of potential genetic biomarkers evaluated for association with an outcome. The challenge in a multiple testing setting is to develop powerful methods to detect meaningful biomarkers while maintaining error control of the false positives, i.e. declaring a biomarker falsely associated with outcome. We have made several scientific contributions in this area.
Oral Health: Miecznikowski collaborated with researchers and faculty in the SUNYAB School of Dental Medicine (SDM) (https://dental.buffalo.edu/). His projects in SDM are related to biomarker development in Sjögren’s syndrome, the oral microbiome’s role in diabetes and oral health, and the symbiosis between the oral and anal microbiome in HIV positive patients.
Traumatic Brain Injury: Miecznikowski actively collaborate with the SUNYAB Concussion Management Clinic (https://ubortho.com/services/concussion-management-center/). He worked on study design and data analysis designed to assess diagnosis, prognosis and effectiveness of novel treatments for concussion and mild traumatic brain injuries.
